山河药辅
(300452)
| 流通市值：23.11亿 | | | 总市值：29.00亿 |
| 流通股本：1.87亿 | | | 总股本：2.34亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 640,355,017.44 | 452,943,330.41 | 247,713,230.6 | 704,525,235.45 |
| 营业收入 | 640,355,017.44 | 452,943,330.41 | 247,713,230.6 | 704,525,235.45 |
| 二、营业总成本 | 515,538,731.29 | 360,280,032.55 | 194,560,102.43 | 585,578,780.47 |
| 营业成本 | 438,613,930.9 | 308,516,726.23 | 167,181,647.68 | 494,755,836.17 |
| 税金及附加 | 4,642,994.3 | 2,760,679.3 | 1,245,789.15 | 6,999,315.96 |
| 销售费用 | 19,619,668.2 | 13,443,034.58 | 6,845,890.79 | 23,282,861.2 |
| 管理费用 | 20,690,248.88 | 13,229,692.11 | 6,155,454.85 | 28,380,194.01 |
| 研发费用 | 30,674,826.71 | 22,230,727.1 | 12,592,178.62 | 34,425,442.89 |
| 财务费用 | 1,297,062.3 | 99,173.23 | 539,141.34 | -2,264,869.76 |
| 其中:利息费用 | 2,468,253.41 | 1,065,663.06 | 376,492.84 | 1,212,543.34 |
| 其中:利息收入 | 1,039,251.33 | 608,639.2 | 314,398.48 | 1,316,362.04 |
| 加:公允价值变动收益 | 7,155,419.96 | 3,288,440.9 | 1,959,252.14 | -2,624,141.18 |
| 加:投资收益 | 3,862,196.5 | 2,715,527.74 | 1,391,267.41 | 7,731,918.2 |
| 资产处置收益 | -14,107.7 | 1,784.19 | 2,627.24 | -274,486.82 |
| 信用减值损失(新) | -2,150.04 | -16,975.59 | 34,338.6 | 56,249.64 |
| 其他收益 | 5,864,989.24 | 3,861,004.38 | 993,086.25 | 12,442,879.95 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 141,682,634.11 | 102,513,079.48 | 57,533,699.81 | 136,278,874.77 |
| 加:营业外收入 | 492,238.27 | 313,994.86 | 166,502.28 | 498,249.84 |
| 减:营业外支出 | 36,290.33 | 58,807.7 | 22,432.6 | 372,374.62 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 142,138,582.05 | 102,768,266.64 | 57,677,769.49 | 136,404,749.99 |
| 减:所得税费用 | 16,449,085.3 | 11,885,513.02 | 6,681,268.84 | 5,470,020.02 |
| 六、净利润 | 125,689,496.75 | 90,882,753.62 | 50,996,500.65 | 130,934,729.97 |
| 持续经营净利润 | 125,689,496.75 | 90,882,753.62 | 50,996,500.65 | 130,934,729.97 |
| 归属于母公司股东的净利润 | 123,531,091.5 | 88,329,256.21 | 49,388,285.35 | 130,708,710.84 |
| 少数股东损益 | 2,158,405.25 | 2,553,497.41 | 1,608,215.3 | 226,019.13 |
| (一)基本每股收益 | 0.53 | 0.38 | 0.21 | 0.56 |
| (二)稀释每股收益 | 0.53 | 0.38 | 0.21 | 0.56 |
| 九、综合收益总额 | 125,689,496.75 | 90,882,753.62 | 50,996,500.65 | 130,934,729.97 |
| 归属于母公司股东的综合收益总额 | 123,531,091.5 | 88,329,256.21 | 49,388,285.35 | 130,708,710.84 |
| 归属于少数股东的综合收益总额 | 2,158,405.25 | 2,553,497.41 | 1,608,215.3 | 226,019.13 |
| 公告日期 | 2023-10-25 | 2023-08-24 | 2023-04-21 | 2023-04-08 |
| 审计意见(境内) | | | | 标准无保留意见 |